Phase I Clinical Study of SPH4336 Tablets in the Treatment of Advanced Solid Tumors
NCT05905614 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 29
Last updated 2024-06-17
Summary
This clinical study evaluated the safety and efficacy of SPH4336 in the treatment of advanced solid tumors.
Conditions
Interventions
- DRUG
-
SPH4336 Tablets
Open-label SPH4336 Tablets ：Administered by oral
Sponsors & Collaborators
-
Shanghai Pharmaceuticals Holding Co., Ltd
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-11-03
- Primary Completion
- 2023-10-26
- Completion
- 2023-10-26
Countries
- China
Study Locations
More Related Trials
-
A Study to Investigate Safety and Tolerability of SH3051 Capsule in Patients With Advanced Solid Tumors
NCT04423380 ·Status: UNKNOWN ·Phase: PHASE1
-
Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors
NCT05037149 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Phase I Study of SY-4835 in Patients With Advanced Solid Tumors
NCT05291182 ·Status: UNKNOWN ·Phase: PHASE1
-
Phase 1 Study of BPI-442096 in Advanced Solid Tumor Patients
NCT05369312 ·Status: UNKNOWN ·Phase: PHASE1
-
ECP-1014 Treatment for Patients With Solid Tumor Cancers
NCT04930354 ·Status: UNKNOWN ·Phase: PHASE1
-
A Phase I/II Clinical Study in Patients with Advanced Solid Tumor.
NCT05970016 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Phase I/II Study of SCTB39-1 in Advanced Solid Tumours
NCT07050641 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study of MHB036C for Advanced Solid Tumor
NCT06373406 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
S-3304 in Treating Patients With Advanced Solid Tumors
NCT00033566 ·Status: COMPLETED ·Phase: PHASE1
-
A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS
NCT05277168 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Clinical Study of SHR-3276 for Injection in Patients With Advanced Malignant Tumors
NCT06643754 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Phase I Study of SHR-A2102 in Patients With Advanced Solid Tumors
NCT05701709 ·Status: RECRUITING ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetic Characteristics, and Efficacy of CM369 in Advanced Solid Tumors & Hematologic Malignancies
NCT05690581 ·Status: RECRUITING ·Phase: PHASE1
-
Safety and Tolerability of SH-1028 in Patients With Advanced Solid Cancer
NCT03618043 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of CSCJC3456 in Patients With Advanced Malignant Tumors
NCT06717750 ·Status: RECRUITING ·Phase: PHASE1
-
A Trial of SHR-7367 in Subjects With Advanced Solid Tumors
NCT05740202 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
An Open Phase I Clinical Trial of SHR-1826 for Injection in Patients With Advanced Solid Tumors
NCT06094556 ·Status: RECRUITING ·Phase: PHASE1
-
A Phase I Study of SHR-4712 in Patients With Advanced Solid Tumors
NCT06993116 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Phase 1 Study of S-3304 in Patients With Solid Tumors
NCT00033215 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Clinical Study of SHR-A2009 for Injection in Patients With Advanced Solid Tumors
NCT05114759 ·Status: UNKNOWN ·Phase: PHASE1
-
Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A in China
NCT03998345 ·Status: UNKNOWN ·Phase: NA
-
Phase I Clinical Study of HWH340 Tablet in Patients With Advanced Solid Tumors
NCT03415659 ·Status: UNKNOWN ·Phase: PHASE1
-
A Study of NB003 in Patients With Advanced Malignancies
NCT04936178 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Trial of TQB3006 Tablets in Patients With Advanced Malignant Cancer
NCT06344351 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase I Study of QLP2117 in Subjects With Advanced Solid Tumors
NCT05830045 ·Status: RECRUITING ·Phase: PHASE1